AI In Drug Repurposing Market

The AI in drug repurposing market involves using artificial intelligence to discover new therapeutic uses for existing drugs. The primary customers are pharmaceutical and biotechnology companies, contract research organizations, and academic institutes. Key growth drivers include the demand for faster, more cost-effective drug development, the rising prevalence of chronic and rare diseases, and significant advancements in machine learning and predictive analytics.